Ipilimumab With Nivolumab for Molecular-selected Patients With Castration-resistant Prostate Cancer
Clinical trial NCT04717154 · COMPLETED
Trial details
- NCT number
- NCT04717154
- Sponsor
- Radboud University Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-19
- Primary completion
- 2024-08-15
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.